<DOC>
	<DOCNO>NCT01708447</DOCNO>
	<brief_summary>This study evaluate efficacy lidocaine topical anesthetic ( numb cream ) reduce discomfort associate Ultherapy™ treatment .</brief_summary>
	<brief_title>Feasibility Study : Evaluate Effectiveness Using Topical Anesthetic Prior Ultherapy™ Treatment</brief_title>
	<detailed_description>All subject receive full face neck Ultherapy™ treatment . Thirty ( 30 ) minute prior treatment , topical anesthetic ( numb cream ) apply one side face neck placebo cream similar consistency color apply side face neck , randomize fashion . The subject investigator sub-investigator perform Ultherapy™ treatment blind side topical anesthetic apply . Pain score collect follow treatment section face neck side . Subjects return 90-day post-treatment visit ass improvement skin laxity , overall lift tighten skin .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Male female , age 30 65 year . Chosen Ultherapy™ treatment part treatment regimen . Subject good health . Skin laxity face neck . Understands accepts obligation undergo procedure area treat followup period . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study Known sensitivity lidocaine anesthetic amide type . History anaphylactic shock . Presence active systemic local skin disease may affect wound healing . Current therapy class I antiarrhythmic drug ( e.g. , tocainide , mexiletine ) . Known suspected hypersensitivity LMX4 active substance , amidetype local anaesthetic , excipients ( protocol section 10.3 ) . Severe solar elastosis . Excessive subcutaneous fat face neck . Body mass index 30 great . Excessive skin laxity face neck . Significant scar area treat . Significant open facial wound lesion . Severe cystic acne face . Presence metal stent implant facial area treat .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>